Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component...
Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...
Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...
Researchers have developed a new approach to T cell therapy that is more effective and less toxic than current treatments. This new approach uses bispecific T cell engagers (BITEs)...
CD99 is highly expressed in T cell acute lymphoblastic leukemia (T-ALL), a type of cancer. One promising treatment involves a mouse monoclonal antibody against CD99 called mAb MT99/3, which...
A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The...
Researchers have developed a new approach to T cell therapy that is more effective in killing breast cancer cells. This new approach uses bispecific T cell engagers (BITEs) to...
A follow-up study on 50 adults investigated the impact of PM2.5 exposure on ocular health. Samples were collected before and after the high PM2.5 season, utilizing data from the...
A new study has explored the potential of generating T lymphocytes from hematopoietic stem cells (HSCs) for cancer immunotherapy. HSCs are a type of cell that can differentiate into...
Researchers from Siriraj Hospital, Mahidol University in Thailand have successfully used a closed, semi-automated production platform to produce anti-CD19 CAR-T cells for the treatment of relapsed/refractory B-cell malignancies. This...